Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LM Partners (now known as Viola-LM Partners) is an Israeli-based private equity and venture capital firm that specializes in investments within the life sciences, medical technology, and high-tech sectors. The firm gained significant prominence in the healthcare industry through its major role in the 2006 recapitalization and subsequent turnaround of Lumenis, one of the world's largest medical laser companies. LM Partners typically targets growth-stage companies and has a history of partnering with other major Israeli investment groups like Ofer Hi-Tech. Its portfolio has included notable healthcare and specialty pharma companies such as Sol-Gel Technologies, PainReform, and Expanding Orthopedics. Today, the firm operates as part of the Viola Group, one of Israel's leading technology-focused investment houses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LM Partners.